NOVELLO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 657
EU - Europa 175
AS - Asia 110
Totale 942
Nazione #
US - Stati Uniti d'America 657
IT - Italia 73
CN - Cina 60
AT - Austria 22
PL - Polonia 18
TR - Turchia 15
GB - Regno Unito 14
SE - Svezia 13
SG - Singapore 13
DE - Germania 12
ID - Indonesia 12
UA - Ucraina 11
BE - Belgio 6
VN - Vietnam 5
KR - Corea 2
RO - Romania 2
RU - Federazione Russa 2
FI - Finlandia 1
FR - Francia 1
IN - India 1
IR - Iran 1
JP - Giappone 1
Totale 942
Città #
Fairfield 96
Chandler 92
Ashburn 68
Woodbridge 66
Ann Arbor 45
Wilmington 34
Seattle 33
Cambridge 32
Ferrara 32
Houston 30
Beijing 23
Vienna 22
Warsaw 18
Princeton 17
Jacksonville 15
Shanghai 13
Izmir 12
Jakarta 12
Milan 11
Nanjing 11
Boardman 8
San Diego 8
Singapore 7
Brussels 6
Dong Ket 5
Cagliari 4
Monterenzio 4
Nanchang 4
Shenyang 4
Addison 3
Bremen 3
Norwalk 3
Ferrara di Monte Baldo 2
Mountain View 2
Muggia 2
Padova 2
Pozzuoli 2
Redwood City 2
Seodaemun-gu 2
Verona 2
Washington 2
Ardabil 1
Augusta 1
Bologna 1
Bordeaux 1
Chandigarh 1
Changchun 1
Des Moines 1
Edinburgh 1
Falls Church 1
Haikou 1
Hanover 1
Hebei 1
Hounslow 1
Jiaxing 1
Kilburn 1
London 1
Los Angeles 1
Mikazura 1
Newcastle upon Tyne 1
Redmond 1
Taizhou 1
Tappahannock 1
Vicenza 1
Totale 782
Nome #
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 147
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists 142
Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia 124
NOP receptor ligands and Parkinson’s disease 81
Autophagy and LRRK2 in the Aging Brain 79
G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice 78
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 70
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance 48
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease 38
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia 37
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity 34
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 31
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice 24
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates 23
STUDY ON THE INTERACTION BETWEEN LRRK2 G2019S MUTATION AND PARKINSONIAN RISK FACTORS 22
Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse 15
Totale 993
Categoria #
all - tutte 6.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 428
Totale 7.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020185 20 5 7 19 10 16 21 19 24 19 17 8
2020/2021192 9 9 8 8 14 5 16 22 20 40 22 19
2021/2022153 3 7 13 3 8 14 15 15 5 10 19 41
2022/2023214 19 36 9 25 33 22 13 13 22 3 10 9
2023/2024128 17 10 4 6 13 14 7 10 4 3 6 34
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 993